VIVE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VIVE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-26), Viveve Medical's current share price is $0.0003. Viveve Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2022 was $592.27. Viveve Medical's Cyclically Adjusted PS Ratio for today is 0.00.
The historical rank and industry rank for Viveve Medical's Cyclically Adjusted PS Ratio or its related term are showing as below:
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Viveve Medical's adjusted revenue per share data for the three months ended in Sep. 2022 was $0.158. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $592.27 for the trailing ten years ended in Sep. 2022.
The historical data trend for Viveve Medical's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viveve Medical Quarterly Data | ||||||||||||||||||||
Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial | - | - | - | - | - |
For the Medical Devices subindustry, Viveve Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Viveve Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Viveve Medical's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Viveve Medical's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 0.0003 | / | 592.27 | |
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viveve Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2022 is calculated as:
For example, Viveve Medical's adjusted Revenue per Share data for the three months ended in Sep. 2022 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Sep. 2022 (Change) | * | Current CPI (Sep. 2022) |
= | 0.158 | / | 125.2265 | * | 125.2265 | |
= | 0.158 |
Current CPI (Sep. 2022) = 125.2265.
Viveve Medical Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201212 | 69.286 | 96.871 | 89.567 |
201303 | 49.714 | 98.209 | 63.390 |
201306 | 53.143 | 98.518 | 67.550 |
201309 | 49.714 | 98.790 | 63.018 |
201312 | 1,281.250 | 98.326 | 1,631.782 |
201403 | 337.500 | 99.695 | 423.935 |
201406 | 456.250 | 100.560 | 568.167 |
201409 | 8.500 | 100.428 | 10.599 |
201412 | 13.000 | 99.070 | 16.432 |
201503 | 19.000 | 99.621 | 23.884 |
201506 | 18.250 | 100.684 | 22.699 |
201509 | 97.333 | 100.392 | 121.411 |
201512 | 107.429 | 99.792 | 134.809 |
201603 | 183.429 | 100.470 | 228.626 |
201606 | 194.500 | 101.688 | 239.522 |
201609 | 168.091 | 101.861 | 206.649 |
201612 | 222.909 | 101.863 | 274.037 |
201703 | 253.417 | 102.862 | 308.515 |
201706 | 161.895 | 103.349 | 196.166 |
201709 | 214.211 | 104.136 | 257.596 |
201712 | 268.474 | 104.011 | 323.235 |
201803 | 142.269 | 105.290 | 169.208 |
201806 | 178.226 | 106.317 | 209.926 |
201809 | 155.516 | 106.507 | 182.850 |
201812 | 124.222 | 105.998 | 146.757 |
201903 | 65.478 | 107.251 | 76.453 |
201906 | 22.870 | 108.070 | 26.501 |
201909 | 17.831 | 108.329 | 20.612 |
201912 | 2.049 | 108.420 | 2.367 |
202003 | 1.460 | 108.902 | 1.679 |
202006 | 0.496 | 108.767 | 0.571 |
202009 | 0.843 | 109.815 | 0.961 |
202012 | 0.897 | 109.897 | 1.022 |
202103 | 0.168 | 111.754 | 0.188 |
202106 | 0.158 | 114.631 | 0.173 |
202109 | 0.153 | 115.734 | 0.166 |
202112 | 0.161 | 117.630 | 0.171 |
202203 | 0.155 | 121.301 | 0.160 |
202206 | 0.169 | 125.017 | 0.169 |
202209 | 0.158 | 125.227 | 0.158 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Viveve Medical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Presnell Sharon Collins | director | 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121 |
Goldman Sachs Group Inc | 10 percent owner | 200 WEST STREET, NEW YORK NY 10282 |
Goldman Sachs & Co. Llc | 10 percent owner | 200 WEST STREET, NEW YORK NY 10282 |
Wilmot B. Harkey | 10 percent owner | C/O NANTAHALA CAPITAL MANAGEMENT, LLC, 130 MAIN ST. 2ND FLOOR, NEW CANAAN CT 06840 |
Daniel Mack | 10 percent owner | C/O NANTAHALA CAPITAL MANAGEMENT, LLC, 130 MAIN ST. 2ND FLOOR, NEW CANAAN CT 06840 |
Nantahala Capital Management, Llc | 10 percent owner | 130 MAIN ST., 2ND FLOOR, NEW CANAAN CT 06840 |
Karen L. Zaderej | director | AXOGEN INC., 13859 PROGRESS BLVD, SUITE 100, ALACHUA FL 32615 |
Steven L Basta | director | 1875 S GRANT STREET SUITE 110, SAN MATEO CA 94402 |
Scott Durbin | officer: Chief Financial Officer | PO BOX 376, ANN ARBOR MI 48106 |
James G. Atkinson | officer: CBO & President | 150 COMMERCIAL STREET, SUNNYVALE CA 94086 |
Patricia Scheller | director, officer: CEO and Director | 150 COMMERCIAL STREET, SUNNYVALE CA 94086 |
Jon M Plexico | director, 10 percent owner | 16430 N SCOTTSDALE RD 450, SCOTTSDALE AZ 85254 |
Stonepine Capital Management, Llc | director, 10 percent owner | 919 NW BOND STREET, SUITE 204, BEND OR 97703 |
Timothy P Lynch | director, 10 percent owner | 919 NW BOND STREET, SUITE 204, BEND OR 97703 |
Daniel Janney | director, 10 percent owner | PO BOX 7414, JACKSON WY 83002 |
From GuruFocus
By ACCESSWIRE ACCESSWIRE • 03-18-2022
By ACCESSWIRE ACCESSWIRE • 09-01-2022
By ACCESSWIRE ACCESSWIRE • 03-03-2022
By ACCESSWIRE ACCESSWIRE • 05-18-2022
By ACCESSWIRE ACCESSWIRE • 01-13-2022
By ACCESSWIRE ACCESSWIRE • 12-01-2022
By ACCESSWIRE ACCESSWIRE • 10-27-2022
By ACCESSWIRE ACCESSWIRE • 08-05-2021
By ACCESSWIRE ACCESSWIRE • 09-23-2021
By ACCESSWIRE ACCESSWIRE • 06-10-2021